Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03VLG
|
|||
| Former ID |
DIB004170
|
|||
| Drug Name |
DCB-WH1
|
|||
| Synonyms |
PAF4 + S1 (wound healing), Development Centre for Biotechnology; PAF4 + S1 (wound healing), Microbio
Click to Show/Hide
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 2 | [1] | |
| Company |
Development Centre for Biotechnology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00709514) Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.